CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa (Q33237178)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

24 July 2017

CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa (English)

1 reference

Europe PubMed Central

24 July 2017

anti-retroviral agent

0 references

Sub-Saharan Africa

0 references

Linda-Gail Bekker

3

object named as

Linda-Gail Bekker

1 reference

Europe PubMed Central

24 July 2017

1

object named as

Stephen D Lawn

1 reference

Europe PubMed Central

24 July 2017

2

object named as

Landon Myer

1 reference

Europe PubMed Central

24 July 2017

4

object named as

Robin Wood

1 reference

Europe PubMed Central

24 July 2017

publication date

21 March 2006

1 reference

Europe PubMed Central

24 July 2017

BMC Infectious Diseases

1 reference

Europe PubMed Central

24 July 2017

6

1 reference

Europe PubMed Central

24 July 2017

59

1 reference

Europe PubMed Central

24 July 2017

copyright license

Creative Commons Attribution 2.0 Generic

21 March 2006

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

https://scigraph.springernature.com/pub.10.1186/1471-2334-6-59

0 references

Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435908

21 June 2018

Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435908

21 June 2018

CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435908

21 June 2018

Development of multiple abscesses in an HIV/TB co-infected patient after initiation of antituberculous and highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435908

21 June 2018

CD4+ T-lymphocyte nadir and the effect of highly active antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435908

21 June 2018

Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435908

21 June 2018

Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-6-59

21 January 2018

Rolling out antiretrovirals in Africa: there are still challenges ahead.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-6-59

21 January 2018

Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-6-59

21 January 2018

Effect of mycophenolate mofetil on immune response and plasma and lymphatic tissue viral load during and after interruption of highly active antiretroviral therapy for patients with chronic HIV infection: a randomized pilot study.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-6-59

21 January 2018

Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-6-59

21 January 2018

Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-6-59

21 January 2018

Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-6-59

21 January 2018

The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-6-59

21 January 2018

Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-6-59

21 January 2018

Long-term changes in circulating CD4 T lymphocytes in virologically suppressed patients after 6 years of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-6-59

21 January 2018

Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-6-59

21 January 2018

Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte dʼIvoire

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435908

31 October 2018

Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach. Executive summary. April 2002

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435908

31 October 2018

Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/ L in HIV Type 1--Infected Individuals Receiving Potent Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-6-59

21 January 2018

Baseline predictors of CD4 T-lymphocyte recovery with combination antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16551345

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for developing tuberculosis in HIV-1-infected adults from communities with a low or very high incidence of tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16551345

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16551345

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design

1 reference

https://pubmed.ncbi.nlm.nih.gov/16551345

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How can earlier entry of patients into antiretroviral programs in low-income countries be promoted?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16551345

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16551345

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16551345

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2334-6-59

1 reference

Europe PubMed Central

24 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

24 July 2017

1 reference

Europe PubMed Central

24 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33237178&oldid=1802512200"